In addition, the tumor-associated production of the granulocyte-macrophage colony stimulating factor or thrombopoietin mediated by IL-6 is considered to be responsible for the increase in the PLT observed in cancer patients [25]. This evidence concerns the gene IL6 and neoplasm.